Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 2/2003

01-05-2003 | Original Article

Fever of unknown origin: a review of 20 patients with Adult-onset Still's disease

Authors: A. Mert, R. Ozaras, F. Tabak, M. Bilir, R. Ozturk, H. Ozdogan, Y. Aktuglu

Published in: Clinical Rheumatology | Issue 2/2003

Login to get access
Metadata
Title
Fever of unknown origin: a review of 20 patients with Adult-onset Still's disease
Authors
A. Mert
R. Ozaras
F. Tabak
M. Bilir
R. Ozturk
H. Ozdogan
Y. Aktuglu
Publication date
01-05-2003
Publisher
Springer-Verlag London Limited
Published in
Clinical Rheumatology / Issue 2/2003
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-002-0680-3

Other articles of this Issue 2/2003

Clinical Rheumatology 2/2003 Go to the issue

LETTER

Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients

ORIGINAL ARTICLE

Functional outcome and subset identification in RA patients from meridional Europe: analysis of a Spanish cohort

ORIGINAL ARTICLE

Serum sIL-2r, IL-6, IL-10 and TNF-α level in familial Mediterranean fever patients

ORIGINAL ARTICLE

Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis

ORIGINAL ARTICLE

Relationship of Interleukin-12 and Interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus

LETTER

Letter to the editor
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits